Best MRI of One Area Doctors Abroad

Op. Dr. Tansu Gürsoy is a brain and nerve surgery specialist at Çerkezköy Private Optimed Hospital. He completed his training at Ankara Training and Research Hospital. His practice focuses on spine surgery. Key areas include degenerative scoliosis, herniated discs, spinal stenosis, trauma, and tumors.

In 2019, he won third place from the Turkish Neurosurgery Association for a paper on prebending rods and sagittal parameters in lumbar degenerative scoliosis. He co-authored Chapter 75 (Lenke-Silva Classification & Adult Degenerative Scoliosis) in The Aging Spine. His thesis analyzed screw malposition in 415 thoracolumbar pedicle fixation cases.

He is a member of the Turkish Neurosurgery Association (Spinal & Peripheral Nerve Surgery Group), the Turkish Spine Association, and the Turkish Medical Association. He completed the Advanced Spinal Surgery Course and the Hands-on Microvascular Anastomosis & Microsurgery training. He holds a Category A Certificate for Experimental Animals. He also attends major spine congresses.

Dr. Park Sundo is a specialist in gastrointestinal and general surgery at Naeun Hospital. His expertise includes colorectal, proctology, breast, thyroid, laparoscopic, biliary, pancreatic, and pediatric surgery.

Key treatments include proctologic surgery, such as hemorrhoidectomy and care for hemorrhoids and anal fistula. He performs laparoscopic surgery for gallstones (cholelithiasis) and appendicitis. His oncology care covers gastric and colorectal cancer. He also performs hernia repair. Breast and thyroid care includes treatment of tumors and Mammotome biopsy. He treats varicose veins and severe burns. Pediatric surgery includes hernia repair and general pediatric procedures.

Dr. Somjet Tosamran is a neurologist at PYONG Rehabilitation Group in Bangkok. He earned his medical degree with First Class Honors from Chulalongkorn University. Dr. Tosamran is currently an epilepsy fellow at King Chulalongkorn Memorial Hospital. He focuses on complex seizure disorders and neurodegenerative conditions.

• Specializes in epilepsy, Parkinson's disease, and Alzheimer's treatment.
• Uses transcranial magnetic stimulation (TMS) for neurological recovery.
• Performs medication management for chronic pain and stroke complications.
• Holds a Master of Science in Internal Medicine from Chulalongkorn University.

Dr. Amphansap specializes in geriatric bone disorders. He uses MRI of one area to evaluate complex hip and shoulder conditions at LUX KOR Hospital.

• Trained in metabolic bone disorders at the University of Sheffield in the UK
• Completed hip reconstruction training at Carl Gustav Carus University Hospital in Germany
• Specialized in shoulder and elbow reconstruction at Berlin's Charite University Hospital
• Certified in orthopedic trauma and surgery by the Police General Hospital

Prof. Beni Boursi leads gastrointestinal oncology research at Sheba Medical Center. He completed advanced training at the University of Pennsylvania and MD Anderson Cancer Center.

• Specializes in oncologic imaging and predictive models for early cancer detection
• Expertise in gastrointestinal oncology used for precise MRI of one area
• Published research in the journal Science regarding innovative cancer therapies
• Founder of the ECOG-ACRIN Microbiome Working Group for global cancer research
• Member of the Israeli Association of Clinical Oncology and Radiotherapy

Dr. Zohar Dotan leads the Department of Urology at Sheba Medical Center. He uses high-resolution MRI of one area to create personalized, precision-based plans for urologic cancers.

• Trained in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering Cancer Center in New York
• Heads the Israeli Uro-Oncology Society and holds a PhD in Genetics
• Member of the American and European Associations of Urology
• Published over 50 scientific papers on cancer treatment and research

Dr. Tara Rak-areekul is a neurologist at PYONG Rehabilitation Group in Bangkok. She ranked first in the Thailand national neurological examination for residents and fellows. Dr. Rak-areekul focuses on cognitive neurology and neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. She holds certifications in NIHSS and acute stroke treatment.

• Uses transcranial magnetic stimulation (TMS) for neurological recovery.
• Won the national Epilepsy Quiz Tournament during her specialized training.
• Researches Alzheimer’s biomarkers and cognitive function at King Chulalongkorn Memorial Hospital.
• Founder of CUMEMO, a digital platform for dementia prevention and education.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Buse Cagla Ari is an Associate Professor at the Medipol University Parkinson’s Center in Istanbul. She focuses on movement disorders, dementia, and chronic pain management. Dr. Ari is a member of the International Parkinson and Movement Disorders Society. She also serves as a peer reviewer for prestigious journals like BMC Neurology.

• Specializes in Parkinson’s disease biomarkers and restless legs syndrome.
• Treats complex neurological conditions including epilepsy and multiple sclerosis.
• Performs specialized nerve blockages and botulinum toxin injections for migraines.
• Published over 15 papers in international medical journals.

Dr. Marek Aleksander Synder is a specialist in Orthopedics and Musculoskeletal Traumatology. He focuses on restoring mobility through non-surgical care and minimally invasive or arthroscopic surgery. He earned his PhD in 2020 for research on Perthes disease.

He is part of the medical team at the Central Teaching Hospital (CKD) in Łódź. He performs surgeries at Księży Młyn Medical Center, Salve Hospital, and the Hospital in Brzeziny.

Clinical scope includes shoulder, hip, knee, pelvic, and groin pain. He treats osteoarthritis and degenerative joint disease. He treats fractures, spinal injuries, and general trauma, as well as overuse conditions such as tennis elbow, heel spurs, and carpal tunnel syndrome.

Dr. Michał Przybył is a specialist in Orthopedics and Musculoskeletal Traumatology. He studied at the Medical University of Łódź and Clark University.

He focuses on minimally invasive joint surgery. He has many years of experience in hip arthroscopy for femoroacetabular impingement (FAI) and labral tears. He also performs total hip and knee replacement and complex ligament reconstruction (ACL, PCL, ATFL).

In-office ultrasound (USG) allows immediate diagnosis and guides treatment. He treats osteoarthritis, hip dysplasia, spine and shoulder conditions, strains, and bunion (hallux) problems. He sees patients in Łódź.

Dr. Gun Keorochana is a spine surgeon at KDMS Specialized Orthopedic Hospital in Bangkok. He earned a medical degree with First Class Honors from Mahidol University. Dr. Keorochana completed a fellowship at the UCLA Comprehensive Spine Center in the US. He specializes in minimally invasive interventions for scoliosis and osteoporosis.

• Expertise includes endoscopic spine surgery, vertebroplasty, and kyphoplasty.
• Completed a visiting fellowship at the Desert Institute for Spine Care in Arizona.
• Performs MIS TLIF and lateral lumbar interbody fusion (LLIF) techniques.
• Works at Thailand’s first dedicated orthopedic-only hospital, which holds AACI accreditation.

Dr. Ulvi Samadzade is a neurologist at Medicalpoint International Hospital in İzmir. He specializes in treating epilepsy, Parkinson’s disease, and multiple sclerosis. He trained at Gazi University and Dokuz Eylul University Hospital. Dr. Samadzade belongs to the International Parkinson and Movement Disorder Society.

• Uses botulinum toxin injections and IVIG therapy for neurological symptom management.
• Treats complex conditions including Alzheimer’s, migraines, and movement disorders.
• Is a member of the European Academy of Neurology.
• Works at JCI-accredited Medicalpoint International Hospital in Turkey.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Song Hwayeong is a gastroenterologist. Areas of focus include gastrointestinal cancers (stomach and esophageal) and advanced endoscopy (gastroscopy, colonoscopy, ESD, and polypectomy). Dr. Song also treats digestive and liver diseases, including GERD, gastritis, hepatitis, H. pylori infection, and liver disease.

Dr. Song completed a fellowship in Gastroenterology at Inje University Ilsan Paik Hospital. Dr. Song has served as Clinical Professor at Inje, Gachon, and Inha University Colleges of Medicine. Dr. Song is Director of the Gastroenterology Center at Naeun Hospital.

Accreditations: full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, and the Korean Gastroenterology Association. Doping Committee Member, WKBL.

Selected papers: cryptogenic hepatocellular carcinoma; primary biliary cirrhosis with overlap syndromes; therapy for lamivudine-resistant chronic hepatitis B; and clevudine in HBV-related cirrhosis.